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Abstract14
Since the discovery of tumour initiating cells (TICs) in solid tumours, studies15
focussing on their role in cancer initiation and progression have abounded. The16
biological interrogation of these cells continues to yield volumes of information on17
their pro-tumourigenic behaviour, but actionable generalised conclusions have been18
scarce. Further, new information suggesting a dependence of tumour composition and19
growth on the microenvironment has yet to be studied theoretically. To address this20
point, we created a hybrid, discrete/continuous computational cellular automaton21
model of a generalised stem-cell driven tissue with a simple microenvironment. Using22
the model we explored the phenotypic traits inherent to the tumour initiating cells23
and the effect of the microenvironment on tissue growth. We identify the regions in24
phenotype parameter space where TICs are able to cause a disruption in homeostasis,25
leading to tissue overgrowth and tumour maintenance. As our parameters and model26
are non-specific, they could apply to any tissue TIC and do not assume specific27
genetic mutations. Targeting these phenotypic traits could represent a generalizable28
therapeutic strategy across cancer types. Further, we find that the29
microenvironmental variable does not strongly effect the outcomes, suggesting a need30
for direct feedback from the microenvironment onto stem-cell behaviour in future31
modelling endeavours.32
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Author Summary:34
In this paper, we present a mathematical/computational model of a tumour growing accord-35
ing to the canonical cancer stem-cell hypothesis with a simplified microenvironment. We36
explore the parameters of this model and find good agreement between our model and other37
theoretical models in terms of the intrinsic cellular parameters, which are difficult to study38
biologically. We find, however, disagreement between novel biological data and our model39
in terms of the microenvironmental changes. We conclude that future theoretical models40
of stem-cell driven tumours must include specific feedback from the microenvironment onto41
the individual cellular behavior. Further, we identify several cell intrinsic parameters which42
govern loss of homeostasis into a state of uncontrolled growth.43
2
Introduction44
Heterogeneity among cancer cells within the same patient contributes to tumour growth and45
evolution. A subpopulation of tumour cells, called Tumour Initiating cells (TICs), or cancer46
stem cells, has recently been shown to be highly tumourigenic in xenograft models and have47
some properties of normal stem cells. Although controversial, there is a growing body of48
evidence that TICs can drive tumour growth and recurrence in many cancers, including, but49
not limited to, brain [1], breast [2] and colon [3]. These tumour types can be broadly classed50
as hierarchical tumours as they have been posited to follow some of the same hierarchical51
organisation as healthy stem-cell (SC) driven tissues. In these hierarchical tumors, TICs can52
differentiate to produce non-TIC cancer cells or self-renew to promote tumor maintenance.53
As TICs have been demonstrated to be resistant to a wide variety of therapies including54
radiation and chemotherapy, the TIC hypothesis has important implications for patient55
treatments [4]. Specifically, the effect of current strategies on the tumor cell hierarchy should56
be defined, and TIC specific therapies are likelyto provide strong benefit for cancer patients.57
In a simplified view of the tumour cell hierarchy, TICs can divide symmetrically or58
asymmetrically to, respectively, produce two TIC daughters or a TIC daughter and a more59
differentiated progeny [5, 6]. More differentiated TIC progeny which still have the capability60
of cell division and are similar to transient amplifying cells (TACs) in the standard stem-61
cell model and are capable of several rounds of their own symmetric division before the62
amplified population then differentiates into terminally differentiated cells (TDs) which are63
incapable of further division. This mode of division and differentiation, which we will call64
the Hierarchical Model (HM) is schematized in Fig 1.65
In the HM, there are a number of cellular behaviours that govern the system. In this66
study, we choose to study three: the rate of symmetric versus asymmetric division of the stem67
cells (α), the number of ‘rounds’ of amplification that transient amplifying cell can undergo68
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Figure 1: Cartoon representing the hierarchical model of stem-cell driven tissues. In this
formulation, each stem can undergo two types of division, either symmetric (with probability
α) or asymmetric (with probability 1−α). Each subsequently generated transient amplifying
cell (TAC) can then undergo a certain number (β) of round of amplification before differen-
tiating into a terminally differentiated cell (TD) which will live for a certain amount of time
before dying (γ timesteps). It is these three parameters, which we assume are intrinsic to a
given stem cell, which we explore in this paper.
before terminal differentiation (β), and the relative lifespan of a terminally differentiated69
cell (γ). While it is a simplification of reality to study only these three parameters and70
leave out others (for example: differing proliferation rates for the different cell types [7]71
or the differing metabolic demands of stem vs. non-stem cells [8]) rigorous quantification72
of these parameters has been extremely difficult to pin down experimentally and so the73
majority of the work to describe them has been in silico. Most germane to the loss of74
homeostasis is the work by Enderling et al. [9] which showed the changes to the size of75
a mutated tissue (tumour) as they varied the number of rounds of amplification of TACs.76
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Other recent work attempting to quantify the ratio of symmetric to asymmetric division in77
putative glioma stem cells was presented by Lathia et al. [10], who showed that this ratio can78
change depending on the medium, suggesting yet another method by which a tissue can lose79
or maintain homeostasis: in reaction to microenvironmental change. A critical limitation80
of in vivo lineage tracing performed to date is an inability to determine the impact of81
microenvironmental heterogeneity on TIC symmetric division.82
While the HM appears to be quite straight forward, there is growing evidence of complex-83
ity to be further incorporated into the model. There are likely to be differences in the extent84
of TIC maintenance or the ability of tumour cells to move toward a TIC state. TICs appear85
to reside in distinct niches suggesting there may be differences in the biology of these cells,86
but defining differences in TICs is limited by cell isolation and tumour initiation methods.87
Prospective isolation of TICs relies on surface markers, including CD133, CD151 and CD2488
which can be transient in nature [11], due to modulation by the tumour microenvironment89
or methods of isolation [12]. Characterisation of these sorted cells then requires functional90
assays including in vitro and in vivo limiting dilution assay as well as determination of91
expression of stem cell factors including Oct4, Nanog and others [13].92
As the importance of TICs becomes more and more evident as it pertains to aspects of93
tumour progression like heterogeneity [14], treatment resistance [15, 16], recurrence [17] and94
metastasis [18], the need for generalizable therapeutic strategies based on conserved motifs95
in these cells grows. We therefore aim to understand how the phenotypic traits discussed96
earlier (asymmetric division rate, allowed rounds of transient amplification and lifespan of97
terminally differentiated cells) and microenvironmental changes (modelled as differences in98
oxygen supply) effect resultant tissue growth characteristics.99
To this end, we present a minimal spatial, hybrid-discrete/continuous mathematical100
model of a hierarchical SC-driven tissue architecture which we have used to explore the101
intrinsic, phenotypic, factors involved in the growth of TIC-driven tumours. We consider102
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parameters that involve the rates of division of the cells involved in the hierarchical cascade103
as well as micro-environmental factors including space and competition between cell types104
for oxygen. We present results suggesting that there are discrete regimes in the intrinsic105
cellular parameter space which allow for disparate growth characteristics of the resulting106
tumours, specifically: TICs that are incapable of forming tumours, TICs that are capable of107
forming only small colonies (spheres), and TICs that are capable of forming fully invasive108
tumours in silico, just as we see diversity in biological experiments (Fig 4).109
Methods110
Our model is based on a hybrid, discrete-continuous cellular automaton model (HCA) of111
a hierarchically structured tissue. HCA models have been used to study cancer progres-112
sion and evolutionary dynamics since they can integrate biological parameters and produce113
predictions affecting different spatial and time scales [14, 19, 20, 21, 22, 23]. As shown in114
figure 2C, cells are modelled in a discrete fashion on a 500x500 2-D lattice. This comprises115
approximately 1cm2 where we assume a cell diameter of 20 micrometers [24]. The domain116
has periodic boundary conditions but the simulations are stopped when a cell reaches one117
of the boundaries. Every time step, cells are iterated in a random fashion as to avoid any118
bias in the way that cells are chosen. Figure 2A shows that, although all cells are assumed119
to have the same size and shape, they can only be one of three different phenotypes: TICs120
capable of infinite divisions, TACs which are capable of division into two daughters for a121
certain number (β) of generations, and TDs which cannot divide but live and consume nu-122
trients for a specified lifetime (γ). Modes of division for TICs include asymmetric division123
(with probability 1 − α), which is division into one TIC daughter and one TAC daughter124
and symmetric division, which is division into two TIC daughters (probability α).125
The continuous portion of this model is made of up the distribution and consumption126
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of nutrients (in this case modelled only as oxygen). Vessels, which are modelled as point127
sources and take up one lattice point (Vi,j in Equation 1), are placed randomly throughout128
the grid at the intiation of a given simulation, in a specified density (Θ). Each of these vessels129
supplies oxygen at a constant rate (λ) which then diffuses into the surrounding tissue. The130
diffusion speed/distance is described by Equation 1, where O(x, y, t) is the concentration of131
oxygen at a given time (t), and place (x, y), DO is the diffusion coefficient of oxygen, λ is the132
rate of oxygen production from a blood vessel, µs, µp, and µt are the rates at which TIC,133
TAC and TD cells consume oxygen. The difference in time scales that govern the diffusion of134
nutrients and that at which cells operate is managed by updating the continuous part of the135
model 100 times per time step. During each update the oxygen tension in a given grid point136
is updated with the values of the surrounding cells using a von Neumann neighbourhood137
modulated by the diffusionrate (DO).138
∂O(x, y, t)
∂t
= DO∇2O(x, y, t) + λVx,y − µSSx,y − µPPx,y − µTTx,y (1)
Any simulation performed by this model can be characterised by the parameters found139
in table 1. The most relevant parameters for the question we are trying to address are the140
following:141
• Symmetric/asymmetric division rate of stem cells (α)142
• Vascular density of the tissue (Θ)143
• Number of allowed divisions of TACs (β)144
• Lifespan of TDs (γ)145
In each case, as can be seen in figure 2, a simulation is seeded with one TIC with a given set146
of intrinsic parameters (α, β, γ) governing its and its progeny’s behaviour, which is placed in147
the centre of the computational domain. The domain is initialised with as many randomly148
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Figure 2: Computational model description. (A) The model includes three different cell
types: stem, progenitor and differentiated. All cell types interact with the microenvironment
in the form of oxygen tension. (B) The behaviour of each cell type is captured by a flowchart.
The last segment with discontinuous arrows represents behaviour that is specific to the stem
cells. (C) The cells are represented as agents inhabiting points in a grid in a 2D space with
500x500 grid points. Stem cells are represented as red points, progenitor as green and fully
differentiated as blue. The vasculature is represented as oxygen source points in black.
placed oxygen source points (vasculature) as described by the vascular density parameter149
(Θ).150
Results151
A systematic parameter exploration of the three key parameters relating to vascularisation152
of the domain, symmetric vs. asymmetric division (α) and progenitor division potential (β)153
was performed. We also explored the parameter determining the lifespan of differentiated154
cells (γ) and found that the only impact of longer lifespans is an increase in the amount155
of time before the simulations reach a steady state, but does not change the qualitative156
nature of the results. These results are summarised in Figure 4. Each of the three panels157
represents the results for a different degree of vascularisation (0.01, 0.05 and 0.1). A density158
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Table 1.
Model parameters.
Parameter value
DO (Oxygen diffusion) 0.001728
λ (Rate of Oxygen production) 1
µs, µp, µT 0.0001
! (Ratio of SC symmetric 
division)
0.1, 0.3, 0.5
" (TAC proliferative potential) 1,5,10,11,12,13,14,15,16,1
7,18,19,20,50,70,100
ɣ (Differentiated cell lifespan) 1
# (Vascularisation) 0.001, 0.01, 0.05, 0.1, 0.5
Any simulation performed by this model can be characterised by the parameters found in table 1 
the most relevant parameters for the question we are trying to address are the following: 
1. Symmetric/asymmetric division rate of stem cells (!)
2. Vascular density in the tissue (#)
3. Number of allowed divisions of transient amplifying cells (")
4. Lifespan of terminally differentiated cells (ɣ) 
In each case, as can be seen in figure 3, a simulation is seeded with one TIC with a given set of 
intrinsic parameters (!, ", Ɣ) governing its and its progeny’s behaviour, which is placed in the 
centre of the computational domain. The domain is initialised with as many randomly placed 
oxygen source points (vasculature) as described by the vascular density parameter.
Results:
Figure 3 shows examples of the typical results produced by this model. Figure 3a shows an 
example of an unviable tissue (parameters: 0.001 for vascularisation, a ratio of symmetric vs 
asymmetric divisions of 0.3, a progenitor replicative potential of 50 and 1 day of lifespan for 
differentiated cells) where the vascularisation does not support the potential tissue size of that 
SC, resulting in an area of hypoxia affecting the region that contains the SC. That leads to the 
death of the stem cell and, eventually, the rest of the cells in the tissue. Figure 3b shows a case 
of slightly increased symmetric division, resulting in a dynamic homeostasis where cell birth and 
death is balanced so that tissue size remains relatively constant. Finally, figure 3c shows an 
example where the system never achieves true homeostasis. In this case the rate of symmetric 
to asymmetric division is slightly higher when compared with the previous example, suggesting 
a critical value at which overgrowth occurs. Over time, the number of SCs increases allowing for 
a larger tissue to be possible. Although this leads to areas of hypoxia, cells survive in the 
periphery of the blood vessels and keep growing until the take over the entire domain. 
A systematic parameter exploration of the three key parameters relating to vascularisation of the 
domain, symmetric vs. asymmetric division (!) and progenitor division potential (") was 
Figure 3: Model parameters.
of vascularisation of 0.05 would mean 12,500 oxygen sources in the domain. To determine159
the diffusion coefficient, we used the estimate of approxi ately 70 micrometers of effective160
oxygenation [25]. Each plot shows the total tissue size after 50,000 time steps as we change161
the proliferative potenti l of progenitor cells. Each of the lines show a different ratio of162
symmetric vs asymmetric divisi s. These results how that all these three parameters hav163
a critical range where homeostasis is disrupted (tumourigenesis).164
Figure 4 shows examples of the typical results produced by this model. Although the165
proliferation rates of all the cells remain the same, due to space constraints and the differences166
in α, the population of TICs does not grow at the same rate as the non-stem population.167
Figure 4A shows an example of an unviable tissue (parameters: Θ = 0.001, α = 0.3, β = 50168
and γ = 1 day) where the vascularisation does not support the potential tissue size of that169
TIC, resulting in an area of hypoxia affecting the region that contains the TIC. That leads to170
the death of the stem cell and, eventually, the rest of the cells in the tissue. Figure 4B shows171
a case of slightly increased sym etric division, resulting in a dynamic homeostasis where172
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Figure 4: Three different examples of simulations resulting from the computational model.
Each simulation represents one of the typical outcomes. Each begins with a single TIC
seeded in the middle of the computational domain and the same vascular density. In each
situation the phenotype parameters are slightly different, resulting in (A) An unsustainable
tissue (parameters: Θ = 0.001, α = 0.3, β = 50 and γ = 1 day), (B) A homeostatic tissue
where the balance of stem cell sell renewal and progenitor proliferation leads to a tissue
whose overall size remains relatively constant over time, possibly representing a dormant
tumor (parameters: Θ = 0.05, α = 0.3, β = 15 and γ = 1 day) and, (C) Neoplastic-like
tissue where the tissue overgrows the computational domain (parameters: Θ = 0.05, α = 0.3,
β = 5 and γ = 1 day). (D) Bright field images of clonal CD133+ patient derived glioblastoma
cell lines cultured in Neurobasal supplemented with EGF, FGF and B27, exhibiting similar
phenotypic variability to the computation model outcomes.
cell birth and death is balanced so that tissue size remains relatively constant - which could173
represent the enigmatic dormant phase [9]. Finally, figure 4C shows an example where the174
system never achieves true homeostasis. In this case α is slightly higher when compared with175
the previous example, suggesting a critical value at which overgrowth occurs. Over time,176
the number of TICs increases, allowing for the ‘tumour phenotype’: unconstrained growth.177
Although this leads to areas of hypoxia, cells survive in the periphery of the blood vessels178
and keep growing until they take over the entire domain.179
Unsurprisingly, the higher the vascularisation of the domain the greater the tissue size180
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it can support. Past a certain threshold, however, the difference becomes negligible and181
more remarkably, the qualitative dynamics are unchanged by any change in the microenvi-182
ronment. The same effect is evident in the other two parameters, the ratio of symmetric vs183
asymmetric division (α) of TICs and the proliferative potential of TACs (β). Regardless of184
the vascularisation, disruption of homeostasis only occurs when the proliferative potential185
of TACs (β) is below a maximum value of about 15. For values of symmetric division (α)186
above 0.3, the values for β in which this overgrowth occurs becomes even more restrictive187
with a range of approximately 10-15.188
Interestingly, we observed a conserved decrease in overall tissue size for the highest value189
of symmetric division, α = 0.5, when the progenitor cells were allowed only 5 divisions190
(β = 5). We believe this phenomenon represents a situation where the tissue is not able to191
grow to its potential as the stem cells themselves occupy too much space, and never allow192
the progenitors to contribute as much as they could to the overall population. This is a193
supposition however, and deserves closer study.194
Figure 5: Size of tissues vs. progenitor proliferative potential achieved by simulations using
different levels of vascularisation and ratios of symmetric vs asymmetric divisions. Lines rep-
resent averages for each of the three realisations in each scenario. (Left). Low vascularisation
density of 0.01 (Centre) Normal vascularisation density of 0.05 (Right) High vascularisation
density of 0.1. In each of these cases, the maximum tissue size will depend on the right
combination of α and β.
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Of note as well: in no simulation did we observe the ‘tumour phenotype’ for a value195
of α < 0.3, suggesting something akin to a ‘phenotypic tumour suppressor’ function for196
this parameter. As observed biologically [10], this ratio is highly susceptible to changes in197
microenvironment, suggesting an extension of this minimal model to include the microenvi-198
ronmental factors measured in that study. How to incorporate the changes observed in that199
study into a mechanistic HCA model however, is not trivial, and we reserve it for a future200
extension of this work.201
Discussion202
In this paper we have presented a simple computational model of the HM of a TIC-driven203
tissue. Our results show that there are distinct regions in parameter space (that directly204
correlate to the intrinsic TIC phenotype space) that encode vastly different behaviour in the205
tissue (or tumour) arising from the TIC in question. These parameters represent different206
TIC phenotypes, and therefore do not represent any specific genetic mutation. In this way,207
we hope to generalise the intrinsic alterations which a TIC could undergo much in the same208
way that the ‘hallmarks of cancer’ have generalised non TIC-specific alterations [26]: our209
end goal being the identification of treatment strategies to target these phenotypes to slow210
or stop the progression of TIC-driven cancers.211
Because of the difficulties in understanding TIC specific traits in vivo, the biological data212
to support these conclusions remains sparse. There have been some carefully undertaken213
in vitro experiments on single TICs in glioblastoma, a highly invasive and malignant brain214
tumour, which suggest that TIC specific division behaviour (α in our model) is variable215
and changes based on environmental cues [10]. Further work has shown that the other216
microenvironmental cues, such as acidity [13] and hypoxia [27, 28, 29, 30, 31, 32, 33] can217
also alter the prevalence of the stem phenotype by utilising functional markers of stemness,218
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but the mechanism for this increase is, as of yet, imperfectly understood.219
Of note, our simulations do not show a significant TIC population dependence on vascular220
density (Θ), a surrogate for hypoxia, or a change in stem composition (see supplemental221
spreadsheet), suggesting a flaw in the model. To rectify this, future iterations of this model222
should include direct feedback onto the cellular parameters from the microenvironment. We223
aim to parameterize this dependence by specific in vitro experiments designed to quantify224
this effect, rather than just elucidate its existence. Other future developments of this model225
should take into consideration the emerging body of work suggesting that the proportion of226
TICs within a tumour is directly affected by therapy and not just physiologic growth factor227
controls [34]. There is now evidence in several cancers to suggest that radiation increases the228
size of the TIC pool. Specifically, in breast cancer, it has been shown that radiation therapy229
induces non-stem cancer cells to de-differentiate into TICs [35]. Further, experimental studies230
have shown radiation increases the TIC pool in glioblastoma [36], which has often been231
attributed to radiation resistance [15] alone. A new study by Gao et al. [37], however, has232
shown in silico and in vitro that radiation can effect the symmetric to asymmetric division233
ratio (our intrinsic parameter α), yielding further clues about the mechanism of this TIC234
pool expansion.235
This behaviour, dedifferentiation due to treatment related microenvironmental factors,236
has not yet been considered in any spatial theoretical models. Dedifferentiation due to237
‘niche’ specific factors was studied by Sottoriva et al. [23], whose findings were similar to238
ours: that the microenvironment made no significant change to the overall tumour growth239
dynamics. Beyond this single spatial study, the concept of SC dedifferentiation is gaining240
more and more attention in conceptual theoretical treatments [38] and has been modelled241
with a deterministic ordinary differential equation system for a well-mixed population of242
cells [39].243
We, as well as others, find that the HM of tissue growth does not completely capture all244
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the necessary dynamics that characterise cancer growth - but there is still a great deal of245
understanding to be gained from studying this formalism. To this end, we have performed246
a study of the factors related to TICs driving this dynamic and have identified several key247
factors which promote increased growth of the resultant tumour. In the same way that248
Hanahan and Weinberg [26] have simplified the myriad (epi)genetic alterations which a249
tumour can undergo into the ‘hallmarks of cancer’ we seek to distill the traits of TICs in the250
same way. Specifically, we have found that the number of allowed divisions of TACs exhibits251
bounds outside of which tumour growth is unsustainable. This finding has been corroborated252
independently by recent work from Morton and colleagues [40]. Further, there is a specific253
balance of symmetric to asymmetric division which keeps tumours from overgrowing; almost254
acting as a phenotypic ‘tumour suppressor’. Indeed, changes in this ratio have been recently255
hypothesized to underlie the increasing stem pool in glioblastoma after irradiation [37], and256
could also represent a key to understanding tumour dormancy [9].257
In summary, we have presented a minimal spatial Hybrid Cellular Automaton model258
of the HM of a TIC-driven tissue in which we have explored generalised TIC phenotypic259
traits and have identified several key cellular parameters which influence the overall tissue260
behaviour. While our model does capture a number of salient phenotypic characteristics of261
TICs that seem to be conserved, it fails to capture the recently observed changes in stem262
fraction secondary to microenvironmental perturbations. This is an indication that any com-263
putational model of a stem-hierarchical tissue, or tumour, built from this point on must not264
only include the physical microenvironment, but also feedback from the microenvironment265
onto the specific cellular parameters encoded in the HM.266
Therefore, this endeavour has identified the crucial point that the microenvironment267
must effect the behaviour of the cells within the HM, and also several conserved phenotypic268
‘hallmarks’, which could be the result of any number of (epi)genetic alterations or microen-269
vironmental perturbations. By focussing on phenotype instead of genotype, and identifying270
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the key points of the HM of stem-cell driven tumour growth, we have provided a begin-271
ning to identification of the therapeutic targets to a more tractable set as compared to the272
panoply of possible mutations encoding similar traits. Only with this sort of distillation of273
the biological complexity inherent to cancer initiation (and indeed progression) can we hope274
to make progress against this disease.275
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